cefixime has been researched along with Gram-Negative Bacterial Infections in 6 studies
Cefixime: A third-generation cephalosporin antibiotic that is stable to hydrolysis by beta-lactamases.
cefixime : A third-generation cephalosporin antibiotic bearing vinyl and (2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(carboxymethoxy)imino]acetamido groups at positions 3 and 7, respectively, of the cephem skeleton. It is used in the treatment of gonorrhoea, tonsilitis, pharyngitis, bronchitis, and urinary tract infections.
Gram-Negative Bacterial Infections: Infections caused by bacteria that show up as pink (negative) when treated by the gram-staining method.
| Excerpt | Relevance | Reference |
|---|---|---|
| "6 microg/ml, respectively with 200 or 400 mg doses of cefditoren pivoxil; plasma concentrations exceed 1 microg/ml for 4 to 6 hours (33-50% of dosing interval)." | 1.31 | Antimicrobial activity and in vitro susceptibility test development for cefditoren against Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus species. ( Beach, ML; Biedenbach, DJ; Johnson, DM; Jones, RN; Pfaller, MA, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Demir, T | 1 |
| Dadali, M | 1 |
| Rawat, D | 1 |
| Hasan, AS | 1 |
| Capoor, MR | 1 |
| Sarma, S | 1 |
| Nair, D | 1 |
| Deb, M | 1 |
| Pillai, P | 1 |
| Aggarwal, P | 1 |
| Capelli, O | 1 |
| Bonucchi, ME | 1 |
| Ragno, T | 1 |
| Azzolini, L | 1 |
| Prandi, E | 1 |
| Lega, M | 1 |
| Toraldo, MD | 1 |
| Velluti, G | 1 |
| Furuya, R | 1 |
| Onoye, Y | 1 |
| Kanayama, A | 1 |
| Saika, T | 1 |
| Iyoda, T | 1 |
| Tatewaki, M | 1 |
| Matsuzaki, K | 1 |
| Kobayashi, I | 1 |
| Tanaka, M | 1 |
| Johnson, DM | 1 |
| Biedenbach, DJ | 1 |
| Beach, ML | 1 |
| Pfaller, MA | 1 |
| Jones, RN | 1 |
| Gok, F | 1 |
| Duzova, A | 1 |
| Baskin, E | 1 |
| Ozen, S | 1 |
| Besbas, N | 1 |
| Bakkaloglu, A | 1 |
1 trial available for cefixime and Gram-Negative Bacterial Infections
| Article | Year |
|---|---|
Comparative study of cefixime alone versus intramuscular ceftizoxime followed by cefixime in the treatment of urinary tract infections in children.
Topics: Adolescent; Cefixime; Ceftizoxime; Child; Child, Preschool; Drug Administration Routes; Female; Gram | 2001 |
5 other studies available for cefixime and Gram-Negative Bacterial Infections
| Article | Year |
|---|---|
Recurrent complicated urinary tract infection due to rare pathogen Sphingomonas paucimobilis: contamination or real deal?
Topics: Anti-Bacterial Agents; Cefixime; Community-Acquired Infections; Diabetes Mellitus, Type 1; Diabetic | 2016 |
In vitro evaluation of a new cefixime-clavulanic acid combination for gram-negative bacteria.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefixime; Clavulanic Acid; Community-Acquired Infections; Cr | 2009 |
Cefixime once-a-day in the treatment of lower respiratory tract infections in adults.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefixime; Drug Administration | 1989 |
Antimicrobial resistance in clinical isolates of Neisseria subflava from the oral cavities of a Japanese population.
Topics: Anti-Bacterial Agents; Cefixime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; F | 2007 |
Antimicrobial activity and in vitro susceptibility test development for cefditoren against Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus species.
Topics: Cefaclor; Cefixime; Cephalosporins; Gram-Negative Bacterial Infections; Haemophilus Infections; Haem | 2000 |